AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26025630 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise (2×60-min sessions for 8 weeks)
Number of subjects: 67
Study 26025630 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aquatic exercise)
Number of subjects: 67
Study 23532957 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in a rectangular-shaped arena
Number of subjects: 0
Study 23532957 — intervention group
Group type: COMPARATOR
Intervention: Search in the rectangular arena
Number of subjects: 0
Study 23532957 — intervention group
Group type: COMPARATOR
Intervention: Search in the kite arena only
Number of subjects: 0
Study 23532957 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer of search between rectangular and kite-shaped arenas
Number of subjects: 0
Study 22947355 — intervention group
Group type: EXPERIMENTAL
Intervention: LCI699 (aldosterone synthase inhibitor)
Number of subjects: 63
Study 22947355 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 63
Study 19655244 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 50,000 IU weekly for 12 weeks
Number of subjects: 60
Study 17636513 — intervention group
Group type: EXPERIMENTAL
Intervention: New age music
Number of subjects: 60
Study 17636513 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of music from one of four styles
Number of subjects: 60
Study 17636513 — intervention group
Group type: COMPARATOR
Intervention: Normal sounds of the operating theatre
Number of subjects: 60
Study 16060749 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of neuroticism
Number of subjects: 242
Study 16060749 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive noise
Number of subjects: 242
Study 12134255 — intervention group
Group type: EXPERIMENTAL
Intervention: Amprenavir (APV) monotherapy
Number of subjects: 31
Study 12134255 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 31
Study 12134255 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine (3TC)
Number of subjects: 31
Study 12134255 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy (ZDV, 3TC, APV)
Number of subjects: 31
Study 10426460 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-esteem module (12-week program)
Number of subjects: 95
Study 10426460 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment only (Control group)
Number of subjects: 95
Study 7576390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose rinse
Number of subjects: 10
Study 7576390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose/maltodextrin rinse (SM)
Number of subjects: 10
Study 7576390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose/maltodextrin/dextrose rinse (SMD)
Number of subjects: 10
Study 7576390 — intervention group
Group type: COMPARATOR
Intervention: Sucrose rinse
Number of subjects: 10
Study 2274431 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomodulin
Number of subjects: 46
Study 2274431 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 46
Study 399953 — intervention group
Group type: EXPERIMENTAL
Intervention: Norephedrine
Number of subjects: 93
Study 399953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 31860096 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI outreach service (intervention hospital/area) for 20 weeks
Number of subjects: 1762
Study 31860096 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI outreach service (intervention hospital/area)
Number of subjects: 1762
Study 31860096 — intervention group
Group type: COMPARATOR
Intervention: Control group (observational control phase)
Number of subjects: 1762
Study 31863573 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Approach (RG)
Number of subjects: 69
Study 31863573 — intervention group
Group type: COMPARATOR
Intervention: Conventional Technique (CG)
Number of subjects: 69
Study 31863573 — intervention group
Group type: COMPARATOR
Intervention: Comparison of RG vs CG
Number of subjects: 69
Study 31671092 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking heaviness (instrumented by genetic variant rs16969968) among ever smokers
Number of subjects: 0
Study 31671092 — intervention group
Group type: COMPARATOR
Intervention: Smoking heaviness (instrumented by genetic variant rs16969968) among never smokers
Number of subjects: 0
Study 28703124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg per day
Number of subjects: 140
Study 28703124 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide 1.5 mg per day
Number of subjects: 140
Study 25739520 — intervention group
Group type: EXPERIMENTAL
Intervention: It's Your Game-Tech (IYG-Tech) program
Number of subjects: 1374
Study 25739520 — intervention group
Group type: EXPERIMENTAL
Intervention: Full exposure (completion of all 13 lessons)
Number of subjects: 1374
Study 25739520 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid exposure (5-8 lessons)
Number of subjects: 1374
Study 23246635 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg IV buprenorphine
Number of subjects: 5
Study 23246635 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg IV buprenorphine
Number of subjects: 5
Study 23246635 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg IV buprenorphine
Number of subjects: 5
Study 23246635 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg IV buprenorphine
Number of subjects: 5
Study 23246635 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg IV buprenorphine
Number of subjects: 5
Study 20670096 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal estradiol (300 μg/day estradiol hemihydrate)
Number of subjects: 44
Study 20670096 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic progesterone (200 mg/day micronized progesterone for 12 days in each cycle) + Intranasal estradiol (300 μg/day estradiol hemihydrate)
Number of subjects: 44
Study 20670096 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 44
Study 19204389 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice (1,450 ppm NaF + 5% KNO3)
Number of subjects: 53
Study 19204389 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference dentifrice (1,450 ppm NaF)
Number of subjects: 53
Study 19204389 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice (0 ppm F)
Number of subjects: 53
Study 16904923 — intervention group
Group type: EXPERIMENTAL
Intervention: One legged knee-extension exercise for 45 minutes
Number of subjects: 18
Study 15327190 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (F)
Number of subjects: 60
Study 15327190 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (A)
Number of subjects: 60
Study 15327190 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (F and A)
Number of subjects: 60
Study 11269574 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 12‐9566 400 mg
Number of subjects: 6
Study 11269574 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 12‐9566 100 mg
Number of subjects: 6
Study 11269574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 11269574 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 6
Study 11269574 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 6
Study 9552067 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral granisetron 2 mg
Number of subjects: 1054
Study 9552067 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ondansetron 32 mg
Number of subjects: 1054
Study 7836534 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa and steroids
Number of subjects: 0
Study 7836534 — intervention group
Group type: COMPARATOR
Intervention: Steroid replacement
Number of subjects: 0
Study 2975554 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 g sucrose
Number of subjects: 17
Study 2975554 — intervention group
Group type: COMPARATOR
Intervention: 30 g starch and saccharin (equivalent sweetness)
Number of subjects: 17
Study 2975554 — intervention group
Group type: EXPERIMENTAL
Intervention: sucrose
Number of subjects: 17
Study 2975554 — intervention group
Group type: COMPARATOR
Intervention: saccharin and starch
Number of subjects: 17
Study 31433717 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy only
Number of subjects: 359
Study 29941037 — intervention group
Group type: EXPERIMENTAL
Intervention: Liuzijue Qigong (LQG), n=50
Number of subjects: 100
Study 29941037 — intervention group
Group type: COMPARATOR
Intervention: Conventional breathing training (control), n=50
Number of subjects: 100
Study 27056996 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (80-120 mg/day on days 1-28, followed by 14 days rest for 1 year)
Number of subjects: 961
Study 27056996 — intervention group
Group type: COMPARATOR
Intervention: UFT (500-600 mg/day on days 1-5, followed by 2 days rest for 1 year)
Number of subjects: 961
Study 27056996 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 961
Study 27056996 — intervention group
Group type: COMPARATOR
Intervention: UFT
Number of subjects: 961
Study 24553886 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive longitudinal approach (MILA)
Number of subjects: 130
Study 24553886 — intervention group
Group type: COMPARATOR
Intervention: Sinus tarsi approach (STA)
Number of subjects: 130
Study 22382665 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil (group F)
Number of subjects: 30
Study 22382665 — intervention group
Group type: COMPARATOR
Intervention: Saline (group C)
Number of subjects: 30
Study 20837354 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761® (240 mg once daily)
Number of subjects: 410
Study 20837354 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study 16740502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to increase fruit and vegetable consumption, physical activity, and daily multivitamin intake; decrease consumption of red meat.
Number of subjects: 0
Study 16740502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to reduce worker exposure to occupational hazards.
Number of subjects: 0
Study 14693585 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.15 micro g/kg
Number of subjects: 90
Study 14693585 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.30 micro g/kg
Number of subjects: 90
Study 14693585 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control Group)
Number of subjects: 90
Study 10705427 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure clinic
Number of subjects: 15
Study 9078199 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (750 mg three times daily for 7 days)
Number of subjects: 214
Study 9078199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 9078199 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 214
Study 8446850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg single dose)
Number of subjects: 139
Study 8446850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1g every 6 hours)
Number of subjects: 139
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: MCBP (melphalan, cyclophosphamide, and carmustine in combination)
Number of subjects: 615
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: Seq‐MCBP (sequential MCBP)
Number of subjects: 615
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: MCBPA (MCBP with doxorubicin)
Number of subjects: 615
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: MP (IV melphalan as the only alkylating agent)
Number of subjects: 615
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: MCBP
Number of subjects: 615
Study 3528403 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan/prednisone regimen
Number of subjects: 615
Study 3065083 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion at a rate of 20 mg kg‐1 h‐1 for 5 min, reducing to 12 mg kg‐1 h‐1 for 10 min and then 6 mg kg‐1 h‐1 thereafter.
Number of subjects: 19
Study 3065083 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 19
Study 3065083 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion following papaveretum premedication
Number of subjects: 19
Study 31074005 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 252
Study 31074005 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 252
Study 28771509 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2mA for 15 minutes)
Number of subjects: 20
Study 28771509 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study 28771509 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 20
Study 25933183 — intervention group
Group type: EXPERIMENTAL
Intervention: DTwP-HepB+Hib vaccine (Pentavac)
Number of subjects: 1510
Study 25933183 — intervention group
Group type: COMPARATOR
Intervention: Tritanrix-HB+Hib vaccine
Number of subjects: 1510
Study 23160979 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined TAP block and local anaesthesia
Number of subjects: 150
Study 23160979 — intervention group
Group type: COMPARATOR
Intervention: Single conventional local anaesthesia
Number of subjects: 150
Study 21667141 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-specific communication with permissive messages
Number of subjects: 0
Study 21667141 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-specific communication with negative alcohol messages
Number of subjects: 0
Study 21667141 — intervention group
Group type: COMPARATOR
Intervention: General parenting style and parental alcohol use
Number of subjects: 0
Study 19234905 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pallidotomy (GPi)
Number of subjects: 10
Study 19234905 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral subthalamotomy (STN)
Number of subjects: 10
Study 19234905 — intervention group
Group type: COMPARATOR
Intervention: Both GPi and STN groups
Number of subjects: 10
Study 16521674 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial acupuncture (n=22)
Number of subjects: 47
Study 16521674 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep acupuncture (n=25)
Number of subjects: 47
Study 16521674 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 47
Study 15225149 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate treatment (adjunctive)
Number of subjects: 36
Study 15225149 — intervention group
Group type: COMPARATOR
Intervention: Metabolic syndrome presence
Number of subjects: 36
Study 15225149 — intervention group
Group type: COMPARATOR
Intervention: Fasting mean total cholesterol
Number of subjects: 36
Study 11765591 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsicum plaster
Number of subjects: 154
Study 11765591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 9422901 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 100 micrograms kg‐1
Number of subjects: 26
Study 9422901 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study 9422901 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodilution
Number of subjects: 26
Study 7684551 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (0.09U (kg BW)‐1 day‐1 sc)
Number of subjects: 22
Study 7684551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7684551 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 22
Study 3101524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen at a dose of 2,400 mg per day
Number of subjects: 61
Study 3101524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 29663316 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 83
Study 29663316 — intervention group
Group type: COMPARATOR
Intervention: Hartmann's procedure
Number of subjects: 83
Study 28490513 — intervention group
Group type: COMPARATOR
Intervention: Maternal and newborn supplementation with vitamin A
Number of subjects: 1613
Study 28490513 — intervention group
Group type: COMPARATOR
Intervention: Both maternal and newborn supplementation with vitamin A
Number of subjects: 1613
Study 26245752 — intervention group
Group type: EXPERIMENTAL
Intervention: ARCHES intervention (brief, clinician-delivered universal education and counseling intervention)
Number of subjects: 3687
Study 26245752 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care control condition
Number of subjects: 3687
Study 23054109 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna use
Number of subjects: 295
Study 23054109 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonwhite and nonblack participants
Number of subjects: 295
Study 21739234 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP‐1
Number of subjects: 60
Study 21739234 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP‐2
Number of subjects: 60
Study 21739234 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP‐9
Number of subjects: 60
Study 17985229 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevention altruism
Number of subjects: 637
Study 17985229 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of altruism
Number of subjects: 637
Study 16829296 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg/kg nitazoxanide as an oral suspension twice a day for 3 days
Number of subjects: 50
Study 16829296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 14572401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive counselling
Number of subjects: 220
Study 14572401 — intervention group
Group type: COMPARATOR
Intervention: Brief counselling (Control)
Number of subjects: 220
Study 11022811 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial treatments for cocaine dependence
Number of subjects: 487
Study 9178340 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch
Number of subjects: 76
Study 9178340 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 76
Study 1489222 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 354
Study 1489222 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins without folic acid
Number of subjects: 354
Study 1489222 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus multivitamins
Number of subjects: 354
Study 1489222 — intervention group
Group type: COMPARATOR
Intervention: Non-randomised control group (pregnant women contacted first)
Number of subjects: 354
Study 3516104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (0.45 mg/kg/day)
Number of subjects: 30
Study 3516104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aspirin (900 mg/day)
Number of subjects: 30
Study 3516104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31802921 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 80
Study 31802921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 29588050 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Life Skills (CLS) program
Number of subjects: 135
Study 29588050 — intervention group
Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 135
Study 27091970 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (Psi) 0.215 mg/kg
Number of subjects: 21
Study 27091970 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 21
Study 25005650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy first with intraoperative cholangiogram
Number of subjects: 100
Study 25005650 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic common duct assessment and clearance followed by cholecystectomy
Number of subjects: 100
Study 22771755 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive norm condition (two friends instructed to restrict intake)
Number of subjects: 3
Study 22771755 — intervention group
Group type: COMPARATOR
Intervention: Control condition (friends not instructed to restrict eating)
Number of subjects: 3
Study 21178922 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 kcal exercise session
Number of subjects: 16
Study 21178922 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 kcal exercise session
Number of subjects: 16
Study 17999012 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic/strength training
Number of subjects: 92
Study 17999012 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training alone
Number of subjects: 92
Study 15049436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol plus dienogest
Number of subjects: 8
Study 15049436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol plus norethisterone acetate
Number of subjects: 8
Study 15049436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol plus levonorgestrel (0.03 mg/0.15 mg)
Number of subjects: 8
Study 15049436 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol plus levonorgestrel (0.02 mg/0.1 mg)
Number of subjects: 8
Study 11669328 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF)
Number of subjects: 50
Study 11669328 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation (CF)
Number of subjects: 50
Study 11669328 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 50
Study 11669328 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional failures
Number of subjects: 50
Study 11669328 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant metastases
Number of subjects: 50
Study 9638316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin (n = 21)
Number of subjects: 84
Study 9638316 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride (n = 21)
Number of subjects: 84
Study 9638316 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (n = 21)
Number of subjects: 84
Study 9638316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 7988253 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection
Number of subjects: 0
Study 7988253 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 0